Who We Are
- Vision
- Team
- International
- Sponsors
- Partners
Companies
Entrepreneurs
Membership
Funds
Knowledge Institute
- Investor Training
- Course Schedule & Registration
Blog & News
Contact Us

Who We Are
- Vision
- Team
- International
- Sponsors
- Partners
Companies
Entrepreneurs
Membership
Funds
Knowledge Institute
- Investor Training
- Course Schedule & Registration
Blog & News
Contact Us

Search

Entrepreneur Login
Member Login

Sign Up For Our Newsletter

Email Newsletter Signup

Name

Email

Company

Facebook Linkedin Twitter

Who We Are
- Vision
- Team
- International
- Sponsors
- Partners
Companies
Entrepreneurs
Membership
Funds
Knowledge Institute
- Investor Training
- Course Schedule & Registration
Blog & News
Contact Us

Who We Are
- Vision
- Team
- International
- Sponsors
- Partners
Companies
Entrepreneurs
Membership
Funds
Knowledge Institute
- Investor Training
- Course Schedule & Registration
Blog & News
Contact Us

Blog > 8/27/20

8/27/20

August 27, 2020

Cognition Therapeutics Announces First Patient Dosed in SEQUEL Study of CT1812.

Who We Are

Vision
Team
International
Sponsors
Partners

Companies

Entrepreneurs

Why Apply to Golden Seeds
Investment Criteria
Apply for Funding
Process & Timing
Office Hours

Angel Network

About Angel Investing
Golden Seeds Angel Network
Interested in Joining?

Funds

Knowledge Institute

Investor Training
Course Schedule & Registration

Blog & News

Golden Seeds Blog
Golden Seeds News
Companies' News

Contact Us

Subscribe to our newsletter

Terms of Use | Copyright © 2024 Golden Seeds